- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01661049
Duodenal Cancer - Retrospective Analysis
August 8, 2012 updated by: Thomas Buchbjerg, Odense University Hospital
1997-2011 Duodenal Cancer Analysis in Southern Denmark
To see how a cohorte of 55 patients over periode 1997-2011 were mannaged, treated and survived duodenal cancer.
Also to see how advanced the tumors were at time of diagnose and at time of operation.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
55
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Odense, Denmark, 5000
- Thomas Buchbjerg
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with duodenal cancer
Description
Inclusion Criteria:
- duodenal cancer
Exclusion Criteria:
- other cancers of the upper GI tract such as pancreatic cancer,
- cholangiocarcinoma,
- papilla Vateri cancer
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2012
Study Registration Dates
First Submitted
August 7, 2012
First Submitted That Met QC Criteria
August 8, 2012
First Posted (Estimate)
August 9, 2012
Study Record Updates
Last Update Posted (Estimate)
August 9, 2012
Last Update Submitted That Met QC Criteria
August 8, 2012
Last Verified
August 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 090377
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Duodenal Cancer
-
Seoul National University HospitalJW PharmaceuticalCompletedInflammatory Bowel Diseases | Gastric Cancer | Pancreatic Cancer | Peptic Ulcer | Colon Cancer | Duodenal Cancer | Biliary CancerKorea, Republic of
-
Bispebjerg HospitalCompleted
-
University Hospital, Strasbourg, FranceRecruitingCongenital Duodenal AtresiaFrance
-
Lightpoint Medical LimitedSemmelweis UniversityWithdrawnGastric Cancer | Pancreatic Cancer | Bile Duct Cancer | Duodenal CancerHungary
-
GlaxoSmithKlinePiramal Clinical Research (Hyderabad, India)Completed
-
Boston Children's HospitalRecruitingDuodenal AtresiaUnited States
-
Wakayama Medical UniversityCompletedPancreatic Cancer | Bile Duct Cancer | Pancreatitis | Duodenal Cancer | Ampullary CancerJapan
-
Wakayama Medical UniversityCompletedPancreatic Cancer | Bile Duct Cancer | Pancreatitis | Duodenal Cancer | Ampullary CancerJapan
-
GlaxoSmithKlinePiramal Clinical Research (Hyderabad, India)Completed
-
Oslo University HospitalActive, not recruitingPancreatic Neoplasms | Pancreatic Cancer | Pancreatic Fistula | Biliary Tract Cancer | Duodenal CancerNorway